Original language | English (US) |
---|---|
Pages (from-to) | 1-45 |
Number of pages | 45 |
Journal | Clinical Infectious Diseases |
Volume | 49 |
Issue number | 1 |
DOIs | |
State | Published - Jul 1 2009 |
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Clinical Infectious Diseases, Vol. 49, No. 1, 01.07.2009, p. 1-45.
Research output: Contribution to journal › Review article › peer-review
}
TY - JOUR
T1 - Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection
T2 - 2009 update by the infectious diseases society of America
AU - Mermel, Leonard A.
AU - Allon, Michael
AU - Bouza, Emilio
AU - Craven, Donald E.
AU - Flynn, Patricia
AU - O'Grady, Naomi P.
AU - Raad, Issam I.
AU - Rijnders, Bart J.A.
AU - Sherertz, Robert J.
AU - Warren, David K.
N1 - Funding Information: Potential conflicts of interest. L.A.M. has received research funding from Angiotech and Theravance and has served as a consultant to Cadence, Ash Access Technology, and CorMedix. M.A. is a consultant for Angiotech and Covidien. E.B. has served on advisory boards for or received research or conference funds from Pfizer, Merck Sharp and Dohme, Cerexa, Cardinal-Health, Sanofi-Aventis, GlaxoSmithKline, Astellas and Astra-Zeneca. D.E.C. has served on the speaker’s bureaus of Pfizer, Wyeth, Sanofi Pasteur, and Merck and has received research funding from Bard, Nomir Medical Technologies, Data and Safety Monitoring Board, and Johnson & Johnson. B.J.A.R. has received research grants from Schering-Plough and Gilead Sciences; has served as a speaker for Bayer, Schering-Plough, Pfizer, and Tibotec; and has served as a consultant to Pfizer and Schering-Plough. P.F. has clinical research contracts with MedImmune and Tibotec. I.I.R. has received research grants from Cubist, Schering-Plough, Versicor, Enzon, Cook Medical, Schering-Plough, and Wyeth; has served on the speaker bureaus of Merck, Pfizer, Cook, and Schering-Plough; has served as a consultant to Clorox, Cubist, and Cook; and has received royalties related to patent licensed to American Medical Systems, Horizon Medical Products, and TyRx on which he is a coinventor. D.K.W. has served on the Pfizer speaker’s bureau; has received research funding from GeneOhm Sciences, Verimetrix, and Astellas Pharma; and has served as a consultant to 3M Healthcare. N.P.O. and R.J.S.: no conflicts.
PY - 2009/7/1
Y1 - 2009/7/1
UR - http://www.scopus.com/inward/record.url?scp=66949140382&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=66949140382&partnerID=8YFLogxK
U2 - 10.1086/599376
DO - 10.1086/599376
M3 - Review article
C2 - 19489710
AN - SCOPUS:66949140382
SN - 1058-4838
VL - 49
SP - 1
EP - 45
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 1
ER -